Target intelligence / Profile preview

Prefoldin subunit 1 (PFDN1)

Target
PFDN1
Molecular classification
Molecular chaperone, Protein folding chaperone, Other (prefoldin complex subunit)
01

Overview

Prefoldin subunit 1 is a protein encoded by the PFDN1 gene. It is one of six subunits (four beta, two alpha) that form the prefoldin complex, a molecular chaperone critical for capturing and stabilizing newly synthesized polypeptide chains, preventing their aggregation and misfolding. Prefoldin primarily binds unfolded actin and tubulin, transferring them to the TRiC/CCT chaperonin complex for proper folding. This activity is ATP-independent and central to cytoskeletal protein homeostasis. Beyond cytoplasmic roles, prefoldin subunits also participate in transcriptional regulation and the proteasome-mediated degradation of proteins. Disruption of prefoldin function is linked to neurodegenerative disorders, cancer, and rare mitochondrial diseases. PFDN1 and the prefoldin complex are increasingly studied as potential therapeutic targets and biomarkers for diseases involving impaired protein folding and cellular stress responses[1][2][3][4][5].

Other names
PFD1PFDN1Prefoldin beta subunit 1
02

Mechanism of action

Stabilization and transfer of unfolded polypeptides to chaperonin complexes for folding; Prevention of protein misfolding and aggregation

03

Biological functions

Protein foldingChaperone-mediated protein foldingCytoskeleton organizationRegulation of protein homeostasisRegulation of protein degradationTranscriptional regulation
04

Disease associations

Neurodegenerative diseaseCancerProgressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2Infection (possible viral involvement)
05

Safety considerations

No specific safety concerns documented; however, as a chaperone involved in global protein homeostasis, modulating PFDN1 might disturb normal folding of essential cellular proteins (theoretical risk) [4]
06

Biomarkers

Possible biomarker candidate for diseases involving proteostasis disruption, neurodegeneration, or cancer (research context) [4]

Beyond the preview

Go deeper on Prefoldin subunit 1 (PFDN1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prefoldin subunit 1 (PFDN1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call